|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-6-10
|
|
pubmed:abstractText |
The utilization of high-potency opioids is an important component of chronic pain management, and appropriate utilization of these medicines is a common concern of payers. Two of the most commonly prescribed oral long-acting opioids, oxycodone controlled-release (CR) and oxymorphone extended-release (ER), are FDA-approved for twice-daily dosing, which equates to a theoretical average consumption (DACON) of 2 tablets per day. DACON values greater than 2 have budget and policy implications for managed care pharmacists.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1944-706X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
367-76
|
|
pubmed:meshHeading |
pubmed-meshheading:21657806-Administration, Oral,
pubmed-meshheading:21657806-Analgesics, Opioid,
pubmed-meshheading:21657806-Chi-Square Distribution,
pubmed-meshheading:21657806-Chronic Disease,
pubmed-meshheading:21657806-Cost Savings,
pubmed-meshheading:21657806-Delayed-Action Preparations,
pubmed-meshheading:21657806-Drug Costs,
pubmed-meshheading:21657806-Drug Prescriptions,
pubmed-meshheading:21657806-Drug Utilization Review,
pubmed-meshheading:21657806-Female,
pubmed-meshheading:21657806-Humans,
pubmed-meshheading:21657806-Insurance, Pharmaceutical Services,
pubmed-meshheading:21657806-Linear Models,
pubmed-meshheading:21657806-Male,
pubmed-meshheading:21657806-Managed Care Programs,
pubmed-meshheading:21657806-Middle Aged,
pubmed-meshheading:21657806-Multivariate Analysis,
pubmed-meshheading:21657806-Oxycodone,
pubmed-meshheading:21657806-Oxymorphone,
pubmed-meshheading:21657806-Pain,
pubmed-meshheading:21657806-Physician's Practice Patterns,
pubmed-meshheading:21657806-Retrospective Studies,
pubmed-meshheading:21657806-Tablets,
pubmed-meshheading:21657806-Time Factors,
pubmed-meshheading:21657806-United States
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets.
|
|
pubmed:affiliation |
Health Outcomes and PharmacoEconomics, Endo Pharmaceuticals, 100 Endo Blvd., Chadds Ford, PA 19317, USA. rubino.mark@endo.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
